Hormone therapy in postmenopausal women associated with increased risk of stroke

Apr 28, 2008

Postmenopausal women taking hormone therapy appear to have an increased risk of stroke regardless of when they started treatment, according to a report in the April 28 issue of Archives of Internal Medicine.

“Many controversies remain regarding the risks and benefits of postmenopausal hormone therapy,” according to background information in the article. There have been previous studies analyzing the risk of stroke with use of hormone therapy, but these did not determine stroke risk for younger women taking hormone therapy near the onset of menopause.

Francine Grodstein, Sc.D., and colleagues, at Brigham and Women’s Hospital (BWH) and Harvard Medical School, Boston, evaluated stroke risk associated with hormone therapy in 121,700 women (age 30 to 55 at the beginning of the study) who participated in the Nurses’ Health Study from 1976 to 2004. There were 360 cases of stroke among women who had never used hormones and 414 cases of stroke among women who were currently using hormones.

Compared to women who had never used hormones, women currently taking hormone therapy had an increased risk for stroke (39 percent for those taking estrogen and 27 percent for those taking estrogen with progestin). “This increased risk was observed for women initiating hormone therapy at young ages or near menopause and at older ages or more than 10 years after menopause,” the authors write. Taking hormone therapy for less than five years at younger ages was not linked to a clear increase in stroke, possibly due to the small number of cases.

“The incidence of stroke was relatively low in younger women, and the attributable risk in women aged 50 through 54 years indicated approximately an additional two cases of stroke per 10,000 women per year taking hormones,” the authors write. There was also a strong relationship found between dose of estrogen and stroke, with larger doses increasing the risk.

Source: JAMA and Archives Journals

Explore further: Wearable artificial kidney safety testing receives go-ahead

add to favorites email to friend print save as pdf

Related Stories

Diabetes vaccine stumbles at second hurdle

Jun 27, 2011

An experimental vaccine to prevent progression of Type 1 diabetes failed at the second step of the three-phase trial process, doctors said on Monday in a study reported online by The Lancet.

Caution for estrogen therapy after hysterectomy

Apr 05, 2011

An editorial in the April 6 issue of the Journal of the American Medical Association cautions against estrogen-only hormone therapy in women who have had a hysterectomy because of longstanding evidence that it raises the ri ...

Recommended for you

Connection found between birth size and brain disorders

14 hours ago

(Medical Xpress)—A trio of researchers has found what appears to be a clear connection between birth size and weight, and the two brain disorders, autism and schizophrenia. In their paper published in Proceedings of ...

A novel therapy for sepsis?

Sep 16, 2014

A University of Tokyo research group has discovered that pentatraxin 3 (PTX3), a protein that helps the innate immune system target invaders such as bacteria and viruses, can reduce mortality of mice suffering ...

User comments : 0